SIMCERE PHARMACEUTICAL GRP LTD revenue for the last year amounted to 7.27 B HKD, the most of which — 7.30 B HKD — came from its highest performing source at the moment, Pharmaceutical Products. The greatest contribution to the revenue figure was made by China — last year it brought SIMCERE PHARMACEUTICAL GRP LTD 7.30 B HKD, and the year before that — 7.35 B HKD.